Most recently, Soufflé Therapeutics raised $200.0M in its Early Stage VC (Series A) (Oct 2025).
- ·The complete investor list: 13 names
- ·Watch Soufflé Therapeutics: the Monday email on marks, rounds and moves
Soufflé Therapeutics round by round
1 roundsHow much has Soufflé Therapeutics raised?
Soufflé Therapeutics has raised $241 million across 1 recorded round since 2025. The largest was a $200 million Series A in Oct 2025.
Soufflé Therapeutics investors
13 investors are on record for Soufflé Therapeutics, including Bessemer Venture Partners, Temasek Holdings, Breyer Capital and ARCH Venture Partners. By type, the record holds 4 venture capital firms, 1 private equity firm and 1 growth equity firm. The Series A in Oct 2025 drew 9 investors.
13 investors have backed Soufflé Therapeutics — start your target list with the firms already writing checks in therapeutic devices.
Frequently asked about Soufflé Therapeutics
- How much has Soufflé Therapeutics raised?
- Soufflé Therapeutics has raised $240.6M in total across 1 recorded funding rounds.
- When was Soufflé Therapeutics's last funding round?
- Soufflé Therapeutics's most recent recorded round was Early Stage VC (Series A) in Oct 2025, raising $200.0M.